Good Natured Products Inc. Announces $2 Million Non-Brokered Private Placement

In This Article:

Vancouver, British Columbia--(Newsfile Corp. - February 14, 2024) - good natured Products Inc. (TSXV: GDNP) (OTCQB: GDNPF) (the "Company" or "good natured?"), a North American leader in plant-based products, today announced a non-brokered private placement financing (the "Offering") for 33,333,333 units (the "Units") of the Company at a price of $0.06 per Unit (the "Issue Price") for aggregate gross proceeds of $2 million. In order to accommodate potential demand from existing and/or new shareholders as outlined below, the Offering is also subject to an over-allotment option, allowing the Company to issue an additional 50,000,000 Units for gross proceeds of $3 million.

Each Unit will consist of one common share in the capital of the Company (a "Unit Share") and one common share purchase warrant (a "Warrant") of the Company. Each Warrant will entitle the holder thereof to acquire one common share (a "Warrant Share") at an exercise price per Warrant Share of $0.08 (the "Warrant Exercise Price") for a period of 30 months from the closing of the Offering.

The Company advises that the Offering will be open to existing shareholders that qualify as "accredited investors" or pursuant to the other available prospectus exemptions under National Instrument 45-106 Prospectus Exemptions in all Provinces of Canada, except Quebec. A minimum subscription amount of $5,000 is required for participation. Please contact the Company by email at [email protected] to discuss participating in the Offering and the exemptions available for you under existing securities law.

In connection with the Offering, the Company may pay certain finders a fee comprised of cash, finder's warrants, or both, based on the proceeds raised from the sale of securities to purchasers introduced to the Company by such finders.

The net proceeds of the Offering are expected to be used by the Company to fund working capital and one-time expenses associated with previously announced cost reduction activities (see press release dated February 14, 2024 and February 1, 2024).

All securities to be issued pursuant to the above referenced Offering will be subject to a statutory four-month hold period. The Offering is subject to a number of conditions, including without limitation, approval of the TSX Venture Exchange.

The Units have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold in the United States or to, for the account or benefit of, "U.S. persons" (as such term is defined in Regulation S under the U.S. Securities Act) absent registration under the U.S. Securities Act or and applicable state securities laws or pursuant to an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws.